You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

The Utility of PET/CT in Colorectal Cancer Metastasis: An Evidence Summary

ID: PET ES-15 jan 2014
Type of Content: Guidelines & Advice, Evidence Summary
Document Status: Current
Authors:
A. Swaminath, S. Kellett, K. Chan, Ontario PET Steering Committee

Guideline Objective

At the request of the Ontario PET Steering Committee, literature pertaining to the utility of PET/CT in the clinical management of patients with extrahepatic colorectal cancer metastasis was summarized.

Patient Population

Patients with new or recurrent colorectal cancer who are potentially eligible for surgical resection of extrahepatic metastasis.

Intended Guideline Users

To guide the Ontario PET Steering Committee in their decision making concerning indications for the use of PET imaging. This evidence summary may also be useful in informing clinical decision making regarding the appropriate role of PET imaging and in guiding priorities for future PET imaging research.

Research Question(s)

In patients with colorectal cancer, what is the role of fluorodeoxyglucose (FDG) PET/CT in determining suitability for surgical removal for isolated lung and abdominal (nodal) metastasis?

pdf download Full Report (PDF) (568.04 Ko)